Journal of Internal Medicine Concepts & Practice ›› 2022, Vol. 17 ›› Issue (01): 43-47.doi: 10.16138/j.1673-6087.2022.01.008
• Expert forum • Previous Articles Next Articles
Received:
2021-11-21
Online:
2022-02-28
Published:
2022-07-25
CLC Number:
[1] |
Trivella J, Levy C. Safety considerations for the management of cholestatic itch[J]. Expert Opin Drug Saf, 2021, 20(8): 915-924.
doi: 10.1080/14740338.2021.1915984 URL |
[2] |
Lieu T, Jayaweera G, Zhao P, et al. The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice[J]. Gastroenterology, 2014, 147(6): 1417-1428.
doi: 10.1053/j.gastro.2014.08.042 URL |
[3] |
Yu H, Zhao T, Liu S, et al. MRGPRX4 is a bile acid receptor for human cholestatic itch[J]. Elife, 2019, 8: e48431.
doi: 10.7554/eLife.48431 URL |
[4] |
Cipriani S, Renga B, D’Amore C, et al. Impaired itching perception in murine models of cholestasis is supported by dysregulation of GPBAR1 signaling[J]. PLoS One, 2015, 10(7): e0129866.
doi: 10.1371/journal.pone.0129866 URL |
[5] |
Yu H, Wangensteen K, Deng T, et al. MRGPRX4 in cholestatic pruritus[J]. Semin Liver Dis, 2021, 41(3): 358-367.
doi: 10.1055/s-0041-1730923 URL |
[6] |
Meixiong J, Vasavda C, Green D, et al. Identification of a bilirubin receptor that may mediate a component of cholestatic itch[J]. Elife, 2019, 8: e44116.
doi: 10.7554/eLife.44116 URL |
[7] |
Patel SP, Vasavda C, Ho B, et al. Cholestatic pruritus: emerging mechanisms and therapeutics[J]. J Am Acad Dermatol, 2019, 81(6): 1371-1378.
doi: 10.1016/j.jaad.2019.04.035 URL |
[8] |
Kittaka H, Uchida K, Fukuta N, et al. Lysophosphatidic acid-induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1/TRPV1[J]. J Physiol, 2017, 595(8): 2681-2698.
doi: 10.1113/JP273961 URL |
[9] |
Tian B, Wang XL, Huang Y, et al. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats[J]. Sci Rep, 2016, 6: 36286.
doi: 10.1038/srep36286 pmid: 27824106 |
[10] |
Ostadhadi S, Kordjazy N, Haj-Mirzaian A, et al. 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice[J]. Fundam Clin Pharmacol, 2015, 29(3): 310-315.
doi: 10.1111/fcp.12112 URL |
[11] |
Shimizu K, Andoh T, Yoshihisa Y, et al. Histamine released from epidermal keratinocytes plays a role in α-melanocyte-stimulating hormone-induced itching in mice[J]. Am J Pathol, 2015, 185(11): 3003-3010.
doi: 10.1016/j.ajpath.2015.07.015 pmid: 26358220 |
[12] |
Andoh T, Suzuki K, Konno M, et al. Pharmacological characterization of a novel mouse model of cholestatic pruritus[J]. Biol Pharm Bull, 2020, 43(7): 1111-1117.
doi: 10.1248/bpb.b20-00097 URL |
[13] |
Bergasa NV. The pruritus of cholestasis: from bile acids to opiate agonists: Relevant after all these years[J]. Med Hypotheses, 2018, 110: 86-89.
doi: S0306-9877(17)31112-X pmid: 29317077 |
[14] |
Moniaga CS, Iwamoto S, Kitamura T, et al. Plasma dynorphin a concentration reflects the degree of pruritus in chronic liver disease[J]. Acta Derm Venereol, 2019, 99(4): 442-443.
doi: 10.2340/00015555-3139 URL |
[15] |
Kumada H, Miyakawa H, Muramatsu T, et al. Efficacy of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus: a randomized, double-blind trial[J]. Hepatol Res, 2017, 47(10): 972-982.
doi: 10.1111/hepr.12830 URL |
[16] | Düll MM, Wolf K, Vetter M, et al. Endogenous opioid levels do not correlate with itch intensity and therapeutic interventions in hepatic pruritus[J]. Front Med (Lausanne), 2021, 8: 641163. |
[17] |
Wang Q, Hao C, Yao W, et al. Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation[J]. BMC Gastroenterol, 2020, 20(1): 59.
doi: 10.1186/s12876-020-01195-1 URL |
[18] |
Kitahata S, Yamamoto Y, Yoshida O, et al. Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis[J]. Sci Rep, 2021, 11(1): 19705.
doi: 10.1038/s41598-021-99314-9 pmid: 34611265 |
[19] |
Rossen NG, Fuentes S, Boonstra K, et al. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured clostridiales Ⅱ[J]. J Crohns Colitis, 2015, 9(4): 342-348.
doi: 10.1093/ecco-jcc/jju023 URL |
[20] |
Zhan Q, Qi X, Weng R, et al. Alterations of the human gut microbiota in intrahepatic cholestasis of pregnancy[J]. Front Cell Infect Microbiol, 2021, 11: 635680.
doi: 10.3389/fcimb.2021.635680 URL |
[21] |
Ji SG, Juran BD, Mucha S, et al. Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease[J]. Nat Genet, 2017, 49(2): 269-273.
doi: 10.1038/ng.3745 URL |
[22] |
Kim MJ, Kim JY, Kang M, et al. Reduced fecal calprotectin and inflammation in a murine model of atopic dermatitis following probiotic treatment[J]. Int J Mol Sci, 2020, 21(11): 3968.
doi: 10.3390/ijms21113968 URL |
[23] |
Kim IS, Lee SH, Kwon YM, et al. Oral administration of β-glucan and lactobacillus plantarum alleviates atopic dermatitis-like symptoms[J]. J Microbiol Biotechnol, 2019, 29(11): 1693-1706.
doi: 10.4014/jmb.1907.07011 URL |
[24] |
Sanjel B, Shim WS. Recent advances in understanding the molecular mechanisms of cholestatic pruritus[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(12): 165958.
doi: 10.1016/j.bbadis.2020.165958 URL |
[25] | De Vloo C, Nevens F. Cholestatic pruritus: an update[J]. Acta Gastroenterol Belg, 2019, 82(1): 75-82. |
[26] | Ahmadi AR, Chicco M, van den Berge M. Rifampicin for treatment of cholestatic pruritus caused by drug-induced acute liver injury as assessed by the RUCAM classification[J]. Case Reports Hepatol, 2020, 2020: 8872804. |
[27] |
Webb GJ, Rahman SR, Levy C, et al. Low risk of hepatotoxicity from rifampicin when used for cholestatic pruritus: a cross-disease cohort study[J]. Aliment Pharmacol Ther, 2018, 47(8): 1213-1219.
doi: 10.1111/apt.14579 URL |
[28] |
Murray-Brown FL. Naltrexone for cholestatic itch: a systematic review[J]. BMJ Support Palliat Care, 2021, 11(2): 217-225.
doi: 10.1136/bmjspcare-2020-002801 URL |
[29] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172.
doi: 10.1016/j.jhep.2017.03.022 URL |
[30] |
Thébaut A, Habes D, Gottrand F, et al. Sertraline as an additional treatment for cholestatic pruritus in children[J]. J Pediatr Gastroenterol Nutr, 2017, 64(3): 431-435.
doi: 10.1097/MPG.0000000000001385 URL |
[31] |
Ovadia C, Lövgren-Sandblom A, Edwards LA, et al. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: case series and mechanism of action[J]. J Clin Apher, 2018, 33(6): 638-644.
doi: 10.1002/jca.21654 URL |
[32] |
Chkheidze R, Joseph R, Burner J, et al. Plasma exchange for the management of refractory pruritus of cholestasis: a report of three cases and review of literature[J]. J Clin Apher, 2018, 33(3): 412-418.
doi: 10.1002/jca.21573 pmid: 28792089 |
[33] |
Pantzaris ND, Lord T, Sotheran R, et al. Nasobiliary drain diverted through a percutaneous endoscopic gastrostomy tube[J]. Case Rep Gastroenterol, 2021, 15(3): 891-897.
doi: 10.1159/000518057 URL |
[34] |
Hussain AB, Samuel R, Hegade VS, et al. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy[J]. Br J Dermatol, 2019, 181(6): 1138-1145.
doi: 10.1111/bjd.17933 pmid: 30920648 |
[35] | Ziogas IA, Alexopoulos SP, Matsuoka LK, et al. Living vs deceased donor liver transplantation in cholestatic liver disease: an analysis of the OPTN database[J]. Clin Transplant, 2020, 34(10): e14031. |
[36] |
Hegade VS, Kendrick SF, Dobbins RL, et al. Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study[J]. Lancet, 2017, 389(10074): 1114-1123.
doi: S0140-6736(17)30319-7 pmid: 28187915 |
[37] |
Al-Dury S, Wahlström A, Wahlin S, et al. Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis[J]. Sci Rep, 2018, 8(1): 6658.
doi: 10.1038/s41598-018-25214-0 pmid: 29704003 |
[1] | XU Doudou, CHEN Ying, LÜ Ankang, WU Beiwen. A retrospective cohort study on the correlation between triglyceride-glucose index and new-onset fatty liver disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 301-306. |
[2] | NING Ling, LIU Zhenjun, LI Wei, LIU Wen, LI Wei, ZHANG Zhenhua, FANG Weidong, GAO Youfang, ZHENG Xiaowei, LI Lei. Pathological and etiological analysis of cholestatic liver disease in Anhui [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 53-57. |
[3] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 84-87. |
[4] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 1-3. |
[5] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 11-14. |
[6] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 15-23. |
[7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 24-28. |
[8] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 29-37. |
[9] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 38-42. |
[10] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(01): 4-10. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||